Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Beta-amyloid deposition and the aging brain.

Rodrigue KM, Kennedy KM, Park DC.

Neuropsychol Rev. 2009 Dec;19(4):436-50. doi: 10.1007/s11065-009-9118-x. Epub 2009 Nov 12. Review.

2.

Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.

Villemagne VL, Rowe CC.

J Alzheimers Dis. 2013;33 Suppl 1:S349-59. Review.

PMID:
22710919
3.

Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.

Hampel H.

J Alzheimers Dis. 2013;33 Suppl 1:S79-86. doi: 10.3233/JAD-2012-129003. Review.

PMID:
22531423
4.

Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain.

Bero AW, Bauer AQ, Stewart FR, White BR, Cirrito JR, Raichle ME, Culver JP, Holtzman DM.

J Neurosci. 2012 Mar 28;32(13):4334-40. doi: 10.1523/JNEUROSCI.5845-11.2012.

5.

Brain amyloid-β oligomers in ageing and Alzheimer's disease.

Lesné SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH.

Brain. 2013 May;136(Pt 5):1383-98. doi: 10.1093/brain/awt062. Epub 2013 Apr 9.

6.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
7.

β-Amyloid burden in healthy aging: regional distribution and cognitive consequences.

Rodrigue KM, Kennedy KM, Devous MD Sr, Rieck JR, Hebrank AC, Diaz-Arrastia R, Mathews D, Park DC.

Neurology. 2012 Feb 7;78(6):387-95. doi: 10.1212/WNL.0b013e318245d295. Epub 2012 Feb 1.

8.

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study.

Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, Szoeke C, Macaulay SL, Martins R, Maruff P, Ames D, Rowe CC, Masters CL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group..

Lancet Neurol. 2013 Apr;12(4):357-67. doi: 10.1016/S1474-4422(13)70044-9. Epub 2013 Mar 8.

PMID:
23477989
9.

Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice.

Murphy MP, Beckett TL, Ding Q, Patel E, Markesbery WR, St Clair DK, LeVine H 3rd, Keller JN.

Neurobiol Dis. 2007 Sep;27(3):301-11. Epub 2007 Jun 12.

PMID:
17651976
10.

Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.

Ribeiro CA, Oliveira SM, Guido LF, Magalhães A, Valencia G, Arsequell G, Saraiva MJ, Cardoso I.

J Alzheimers Dis. 2014;39(2):357-70. doi: 10.3233/JAD-131355.

PMID:
24169237
11.

Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.

Bi Oh S, Suh N, Kim I, Lee JY.

Brain Res. 2015 Feb 9;1597:159-67. doi: 10.1016/j.brainres.2014.11.042. Epub 2014 Nov 29.

PMID:
25454795
12.

Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice.

Meilandt WJ, Cisse M, Ho K, Wu T, Esposito LA, Scearce-Levie K, Cheng IH, Yu GQ, Mucke L.

J Neurosci. 2009 Feb 18;29(7):1977-86. doi: 10.1523/JNEUROSCI.2984-08.2009.

13.

Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.

Müller-Schiffmann A, Herring A, Abdel-Hafiz L, Chepkova AN, Schäble S, Wedel D, Horn AH, Sticht H, de Souza Silva MA, Gottmann K, Sergeeva OA, Huston JP, Keyvani K, Korth C.

Brain. 2016 Feb;139(Pt 2):509-25. doi: 10.1093/brain/awv355. Epub 2015 Dec 10.

PMID:
26657517
14.

Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).

Rockenstein E, Mallory M, Mante M, Sisk A, Masliaha E.

J Neurosci Res. 2001 Nov 15;66(4):573-82.

PMID:
11746377
15.

Interactions between amyloid-β and hemoglobin: implications for amyloid plaque formation in Alzheimer's disease.

Chuang JY, Lee CW, Shih YH, Yang T, Yu L, Kuo YM.

PLoS One. 2012;7(3):e33120. doi: 10.1371/journal.pone.0033120. Epub 2012 Mar 6.

16.

Lifespan brain activity, β-amyloid, and Alzheimer's disease.

Jagust WJ, Mormino EC.

Trends Cogn Sci. 2011 Nov;15(11):520-6. doi: 10.1016/j.tics.2011.09.004. Epub 2011 Oct 7.

17.

CR1 is associated with amyloid plaque burden and age-related cognitive decline.

Chibnik LB, Shulman JM, Leurgans SE, Schneider JA, Wilson RS, Tran D, Aubin C, Buchman AS, Heward CB, Myers AJ, Hardy JA, Huentelman MJ, Corneveaux JJ, Reiman EM, Evans DA, Bennett DA, De Jager PL.

Ann Neurol. 2011 Mar;69(3):560-9. doi: 10.1002/ana.22277. Epub 2011 Mar 9.

18.
19.

Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis.

Lucey BP, Bateman RJ.

Neurobiol Aging. 2014 Sep;35 Suppl 2:S29-34. doi: 10.1016/j.neurobiolaging.2014.03.035. Epub 2014 May 15. Review.

20.

Amyloid β-peptide and Alzheimer's disease.

Allsop D, Mayes J.

Essays Biochem. 2014;56:99-110. doi: 10.1042/bse0560099.

PMID:
25131589

Supplemental Content

Support Center